Aptose Biosciences Inc. (APTO) is priced at $5.53 after the most recent trading session. At the very opening of the session, the stock price was $5.46 and reached a high price of $5.69, prior to closing the session it reached the value of $5.35. The stock touched a low price of $5.35.
Recently in News on June 1, 2021, Aptose Biosciences Announces Results of Annual Meeting of Shareholders. Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced the voting results from the Company’s annual and special meeting of shareholders held today, June 1, 2021 (the “Meeting”). A total of 72.83% of the issued and outstanding common shares of the Company were represented by shareholders present or represented by proxy at the Meeting. You can read further details here
Aptose Biosciences Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $7.20 on 03/24/21, with the lowest value was $3.39 for the same time period, recorded on 03/05/21.
Aptose Biosciences Inc. (APTO) full year performance was -20.32%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Aptose Biosciences Inc. shares are logging -24.45% during the 52-week period from high price, and 63.12% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.39 and $7.32.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1544291 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Aptose Biosciences Inc. (APTO) recorded performance in the market was 26.26%, having the revenues showcasing 40.36% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 506.55M, as it employees total of 39 workers.
Analysts verdict on Aptose Biosciences Inc. (APTO)
During the last month, 0 analysts gave the Aptose Biosciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.81, with a change in the price was noted +1.13. In a similar fashion, Aptose Biosciences Inc. posted a movement of +25.68% for the period of last 100 days, recording 2,964,282 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for APTO is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Aptose Biosciences Inc. (APTO): Technical Analysis
Raw Stochastic average of Aptose Biosciences Inc. in the period of last 50 days is set at 58.96%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 79.91%. In the last 20 days, the company’s Stochastic %K was 74.43% and its Stochastic %D was recorded 76.09%.
Let’s take a glance in the erstwhile performances of Aptose Biosciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 26.26%. Additionally, trading for the stock in the period of the last six months notably improved by 18.67%, alongside a downfall of -20.32% for the period of the last 12 months. The shares increased approximately by 1.84% in the 7-day charts and went down by 14.49% in the period of the last 30 days. Common stock shares were driven by 40.36% during last recorded quarter.